VCYT Veracyte, Inc.
$44.65 -6.34%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-6.34%
YTD
+29.00%
P/E
31.03
P/B
2.54
ROE
8.6%
Div yield
—
Beta
1.41
Market cap
$3.6B
RSI (14)
50
Next earnings
Nov 2, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$47.99
Close
$44.65
VWAP (n/a)
—
Day high
$48.84
Day low
$44.09
Volume
1.7M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Veracyte (VCYT) Is Down 9.0% After New Level 1B1 Decipher Prostate Data at ASTRO 2026
Yahoo Finance · Oct 2
Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation
Yahoo Finance · Sep 29
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
Yahoo Finance · Oct 6
Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares
Yahoo Finance · Oct 6
Veeva's OpenData to Help Servier Build a Global AI Data Foundation
Yahoo Finance · Oct 5
Could Veracyte (VCYT) Change Prostate Cancer Care With New Phase III Data?
Yahoo Finance · Oct 1
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 14, 2026 View → 10-Q Jul 31, 2026 View → 8-K Jul 30, 2026 View → 8-K Jun 11, 2026 View → 10-Q May 6, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell VCYT. Try it in the Lab to size a position and see the risk.